In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains

Anaerobe

Volumn 20, Issue , 2013, Pages 36-41

  Schoster, A ^a   Kokotovic, B ^b   Permin, A ^b   Pedersen, P D ^c   Bello, F Dal ^c   Guardabassi, L ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c Clerici Sacco Group   (Italy)

Author keywords

Clostridium difficile; Clostridium perfringens; Inhibition; Lactobacillus ssp; Probiotics

Indexed keywords

ACID; ANTIBIOTIC AGENT; BACTERIOCIN; PROBIOTIC AGENT;

AGAR DIFFUSION; ANTIBACTERIAL ACTIVITY; ANTIBIOSIS; ARTICLE; BACTERIAL GROWTH; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS LACTIS; BILE; BROTH DILUTION; CELL FREE SYSTEM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTION; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DRUG EFFICACY; ENTEROCOCCUS FAECIUM; GASTROINTESTINAL TRACT; GROWTH INHIBITION; IN VITRO STUDY; INTESTINE INFECTION; LACTOBACILLUS BREVIS; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; LACTOBACILLUS HELVETICUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SAKEI; LACTOBACILLUS SALIVARIUS; LIQUID CULTURE; NONHUMAN; PH; PRIORITY JOURNAL; SIMULATION; SUPERNATANT;

ANTIBIOSIS; BACTERIOCINS; BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; CULTURE MEDIA, CONDITIONED; HUMANS; HYDROGEN-ION CONCENTRATION; LACTOBACILLUS; MICROBIAL SENSITIVITY TESTS; PROBIOTICS;

ANIMALIA; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; CLOSTRIDIA; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; LACTOBACILLUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS;

EID: 84875624651     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2013.02.006     Document Type: Article

References (39)

1. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009, 7:526-536.
2. Weese J.S., Staempfli H.R., Prescott J.F. A prospective study of the roles of clostridium difficile and enterotoxigenic Clostridium perfringens in equine diarrhoea. Equine Vet J 2001, 33:403-409.
3. Baverud V., Gustafsson A., Franklin A., Aspan A., Gunnarsson A. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility. Equine Vet J 2003, 35:465-471.
4. Waters M., Savoie A., Garmory H.S., Bueschel D., Popoff M.R., Songer J.G., et al. Genotyping and phenotyping of beta2-toxigenic Clostridium perfringens fecal isolates associated with gastrointestinal diseases in piglets. J Clin Microbiol 2003, 41:3584-3591.
5. Weese J.S., Toxopeus L., Arroyo L. Clostridium difficile associated diarrhoea in horses within the community: predictors, clinical presentation and outcome. Equine Vet J 2006, 38:185-188.
6. Baverud V., Gustafsson A., Franklin A., Lindholm A., Gunnarsson A. Clostridium difficile associated with acute colitis in mature horses treated with antibiotics. Equine Vet J 1997, 29:279-284.
7. Songer J.G., Uzal F.A. Clostridial enteric infections in pigs. J Vet Diagn Invest 2005, 17:528-536.
8. Yaeger M., Funk N., Hoffman L. A survey of agents associated with neonatal diarrhea in Iowa swine including Clostridium difficile and porcine reproductive and respiratory syndrome virus. J Vet Diagn Invest 2002, 14:281-287.
9. Songer J.G. The emergence of Clostridium difficile as a pathogen of food animals. Anim Health Res Rev 2004, 5:321-326.
10. Keessen E.C., Hopman N.E., van Leengoed L.A., van Asten A.J., Hermanus C., Kuijper E.J., et al. Evaluation of four different diagnostic tests to detect Clostridium difficile in piglets. J Clin Microbiol 2011, 49:1816-1821.
11. Waters M., Raju D., Garmory H.S., Popoff M.R., Sarker M.R. Regulated expression of the beta2-toxin gene (cpb2) in Clostridium perfringens type a isolates from horses with gastrointestinal diseases. J Clin Microbiol 2005, 43:4002-4009.
12. Guarner F., Schaafsma G.J. Probiotics. Int J Food Microbiol 1998, 39:237-238.
13. Hickson M. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Ther Adv Gastroenterol 2011, 4:185-197.
14. Gao X.W., Mubasher M., Fang C.Y., Reifer C., Miller L.E. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010, 105:1636-1641.
15. Na X., Kelly C. Probiotics in clostridium difficile Infection. J Clin Gastroenterol 2011, 45(Suppl.):S154-S158.
16. Desrochers A.M., Dolente B.A., Roy M.F., Boston R., Carlisle S. Efficacy of Saccharomyces boulardii for treatment of horses with acute enterocolitis. J Am Vet Med Assoc 2005, 227:954-959.
17. Parraga M.E., Spier S.J., Thurmond M., Hirsh D. A clinical trial of probiotic administration for prevention of Salmonella shedding in the postoperative period in horses with colic. J Vet Intern Med 1997, 11:36-41.
18. Casey P.G., Gardiner G.E., Casey G., Bradshaw B., Lawlor P.G., Lynch P.B., et al. A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica Serovar Typhimurium. Appl Environ Microbiol 2007, 73:1858-1863.
19. Weese J.S., Anderson M.E., Lowe A., Monteith G.J. Preliminary investigation of the probiotic potential of Lactobacillus rhamnosus strain GG in horses: fecal recovery following oral administration and safety. Can Vet J 2003, 44:299-302.
20. Collado M.C., Grzeskowiak L., Salminen S. Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa. Curr Microbiol 2007, 55:260-265.
21. Dobson A., Crispie F., Rea M.C., O'Sullivan O., Casey P.G., Lawlor P.G., et al. Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract. FEMS Microbiol Ecol 2011, 76:602-614.
22. Chaucheyras-Durand F., Durand H. Probiotics in animal nutrition and health. Benef Microbe. 2010, 1:3-9.
23. Mattila-Sandholm T., Myllarinen P., Crittenden R., Mogensen G., Fonden R., Saarela M. Technological challenges for future probiotic foods. Int Dairy J 2002, 12:173-182.
24. Culligan E.P., Hill C., Sleator R.D. Probiotics and gastrointestinal disease: successes, problems and future prospects. Gut Pathog 2009, 1:19.
25. Weese J.S., Anderson M.E., Lowe A., Penno R., da Costa T.M., Button L., et al. Screening of the equine intestinal microflora for potential probiotic organisms. Equine Vet J 2004, 36:351-355.
26. Collado M.C., Hernandez M., Sanz Y. Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains. J Food Prot 2005, 68:1034-1040.
27. Hacin B., Rogelj I., Matijasic B.B. Lactobacillus isolates from weaned piglets' mucosa with inhibitory activity against common porcine pathogens. Folia Microbiol (Praha) 2008, 53:569-576.
28. Wang Q., Cui Y., Wang W., Xu J., Xu L. Production of two bacteriocins in various growth conditions produced by gram-positive bacteria isolated from chicken cecum. Can J Microbiol 2012, 58:93-101.
29. Gong H.S., Meng X.C., Wang H. Mode of action of plantaricin MG, a bacteriocin active against Salmonella typhimurium. J Basic Microbiol 2010, 50(Suppl. 1):S37-S45.
30. Tsapieva A., Duplik N., Suvorov A. Structure of plantaricin locus of Lactobacillus plantarum 8P-A3. Benef Microbe. 2011, 2:255-261.
31. Bhunia A.K., Johnson M.C., Ray B. Purification, characterization and antimicrobial spectrum of a bacteriocin produced by Pediococcus acidilactici. J Appl Bacteriol 1988, 65:261-268.
32. Rodriguez J.M., Martinez M.I., Kok J. Pediocin PA-1, a wide-spectrum bacteriocin from lactic acid bacteria. Crit Rev Food Sci Nutr 2002, 42:91-121.
33. Kalchayanand N., Hanlin M.B., Ray B. Sublethal injury makes gram-negative and resistant gram-positive bacteria sensitive to the bacteriocins, pediocin AcH and nisin. Lett Appl Microbiol 1992, 15:239-243.
34. Rodriguez-Palacios A., Staempfli H.R., Duffield T., Weese J.S. Isolation of bovine intestinal Lactobacillus plantarum and Pediococcus acidilactici with inhibitory activity against Escherichia coli O157 and F5. J Appl Microbiol 2009, 106:393-401.
35. Botha M., Botes M., Loos B., Smith C., Dicks L.M. Lactobacillus equigenerosi strain Le1 invades equine epithelial cells. Appl Environ Microbiol 2012, 78:4248-4255.
36. FAO/WHO Working group for drafting guidelines for the evaluation of probiotics in food 2002, ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
37. Todorov S.D., Leblanc J.G., Franco B.D. Evaluation of the probiotic potential and effect of encapsulation on survival for Lactobacillus plantarum ST16Pa isolated from papaya. World J Microbiol Biotechnol 2012, 28:973-984.
38. Dunne C., Murphy L., Flynn S., O'Mahony L., O'Halloran S., Feeney M., et al. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek 1999, 76:279-292.
39. Collado M.C., Gueimonde M., Hernandez M., Sanz Y., Salminen S. Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion. J Food Prot 2005, 68:2672-2678.